Table 1.
Studies on Endarterectomy and Endovascular Therapy of the Common Femoral Artery
| Procedure | n | Age (Mean) | Male (%) | DM (%) | CLI (%) | DCB (%) | Stent (%) | Mortality (%) | Amputation (%) | PP (%) | TLR (%) | Follow-Up (yrs) | Predictors of Restenosis | Predictors of TLR | Ref |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endarterectomy | |||||||||||||||
| E** | 117 | 70.8 | 75.2 | 31.6 | 40 | 0 | 0 | 20 | 0 | 96 | 21 | 7 | Rutherford 5,6, malnutrition, poor tibial runoff, type of platelet inhibitors other than clopidogrel | # | 1 |
| E** | 121 | 68.7 | 76 | 28 | 39.4 | 0 | 0 | 23.1 | 3.5 | 93.2 | 1.6 | 2 | Cancer and postoperative complications especially lymphorrhea | # | 2 |
| E^ | 655 | 69.4 | 75 | 41.2 | 31 | 0 | 0 | 39.9 | 7.4 | 78.5 | 10.7 | 7 | # | # | 4 |
| Endovascular | |||||||||||||||
| PTA** | 321 | 67.6 | 81 | 38.6 | 22.1 | 0 | 36.9 | 9 | 0.3 | 72.4 | 19.9 | 1 | Other lesions than isolated CFA; inversely associated with stent use | Other lesions than isolated CFA; inversely associated with stent use | 5 |
| Stent** | 53 | 68 | 81 | 41 | 32.1 | 0 | 95 | 11.5 | 6 | 92.5 | 3 | 2 | # | # | 6 |
| Stent** | 36 | 67.9 | 83 | 25 | 30 | 0 | 100 | 5 | 2.8 | 80 | 11.1 | 1 | No risk factors were found to be predictors of restenosis | Age | 7 |
| Stent** | 36 | 67.9 | 83 | 25 | 30 | 0 | 100 | 38 | 5.6 | 72 | 21 | 5 | Deep femoral artery stenting and type III lesions (involve CFA and branches) | # | 8 |
| ATH and DCB** | 30 | 78 | 84 | 60 | 94 | 100 | 10 | 0 | 0 | 90 | 6.7 | 1 | # | # | 18 |
| Stent/PTA/ATH^ | 1014 | 67.4 | 59 | 46.7 | 16.3 | 0 | 27.3 | 7.1 | 6.5 | 83 | 14.7 | 1 | Tissue loss, emergency procedure and non-ambulatory status | # | 9 |
| PTA^ | 93 | 72 | 76 | 53 | 19 | 0 | 9 | 32.8 | # | 46.9 | # | 5 | Renal failure, CAD, Calcified disease, residual stenosis | # | 13 |
| ATH and DCB^ | 21 | 73 | 48 | 38 | 29 | 100 | 4.8 | 23.8 | 4.8 | 88 | 11 | 1 | # | # | 17 |
Notes: **Prospective data collected, ^Retrospective, #Info not provided.
Abbreviations: DM, diabetes Mellitus; CLI, critical limb ischemia; DCB, drug-coated balloon; PP, primary patency; TLR, target lesion revascularization; Ref, reference.